The Joint Corp.

NasdaqCM JYNT

The Joint Corp. Price to Earnings Ratio (P/E) on January 14, 2025: -9.08

The Joint Corp. Price to Earnings Ratio (P/E) is -9.08 on January 14, 2025, a 34.49% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

The Joint Corp. 52-week high Price to Earnings Ratio (P/E) is -8.80 on December 27, 2024, which is 3.13% above the current Price to Earnings Ratio (P/E).
The Joint Corp. 52-week low Price to Earnings Ratio (P/E) is -23.80 on May 16, 2024, which is -161.97% below the current Price to Earnings Ratio (P/E).
The Joint Corp. average Price to Earnings Ratio (P/E) for the last 52 weeks is -14.26.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

NasdaqCM: JYNT

The Joint Corp.

CEO	Mr. Sanjiv Razdan
IPO Date	Nov. 11, 2014
Location	United States
Headquarters	16767 North Perimeter Drive
Employees	444
Sector	Health Care
Industries Hospitals & Clinics

Description

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

Key trends

Past 5 years